John Halbrook MD has Medical Oncology as his primary medical specialty. Their primary office is: 1704 23rd Ave in Meridian, Mississippi.
They're a part of the: Meridian Oncology Associates Pllc medical group which has around 4 members. You can call their office at 601-482-1555 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended University Of Mississippi School Of Medicine and graduated in 1974 (around 50 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.
John Halbrook MD
Meridian Oncology Associates Pllc
1704 23rd Ave
Meridian, Mississippi 39301
601-482-1555
Phone: 601-482-1555
Enter a starting address:
Additional Medical Specialties Include:
HEMATOLOGY/ONCOLOGY, INTERNAL MEDICINE
Medical School: University Of Mississippi School Of Medicine
Graduation Year: 1974
The Primary Medical Specialty for John Halbrook MD is listed as: Medical Oncology
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 50
PAC (PECOS ID)#: 5294620829
NPI #: 1992782924
NPI Created On: 12/30/2005
NPI Last Updated Listed as: 10/22/2020
Primary Taxonomy Code: 174400000X
License Number:
07013
Listed Gender: Male
Forms of insurance accepted by include, but are not limited to:
They are listed as accepting new patients.
Languages spoken by staff include: English.
Services and Procedures include:
Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.
Payments Total: $100
Number of Payments:: 1
Form of Payment: In-kind items and services
Third party is a Charity:: No
Record ID:: 788902117
Being Disputed:: No
Product Related: Yes
Drug or Biological: Drug
Product Category #1: Oncology
Name of Drug #1: ERLEADA
Open Associated Drug #1: 59676-600-12
Payments Total: $15
Number of Payments:: 1
Form of Payment: In-kind items and services
Third party is a Charity:: No
Record ID:: 788902119
Being Disputed:: No
Product Related: Yes
Drug or Biological: Biological
Product Category #1: Oncology
Name of Drug #1: DARZALEX
Open Associated Drug #1: 57894-502-05
Payments Total: $12
Number of Payments:: 1
Form of Payment: In-kind items and services
Third party is a Charity:: No
Record ID:: 788902123
Being Disputed:: No
Product Related: Yes
Drug or Biological: Drug
Product Category #1: Oncology
Name of Drug #1: IMBRUVICA
Open Associated Drug #1: 57962-140-09
Drug or Biological: Drug
Product Category #2: Oncology
Name Of Drug #2:: DARZALEX
Associated Drug #2: 57894-502-05
Payments Total: $8
Number of Payments:: 1
Form of Payment: In-kind items and services
Third party is a Charity:: No
Record ID:: 788902121
Being Disputed:: No
Product Related: Yes
Drug or Biological: Drug
Product Category #1: Oncology
Name of Drug #1: ERLEADA
Open Associated Drug #1: 59676-600-12
Drug or Biological: Drug
Product Category #2: Oncology
Name Of Drug #2:: BALVERSA
Associated Drug #2: 59676-030-56
Payments Total: $12
Number of Payments:: 1
Form of Payment: In-kind items and services
Third party is a Charity:: No
Record ID:: 788902125
Being Disputed:: No
Product Related: Yes
Drug or Biological: Drug
Product Category #1: Oncology
Name of Drug #1: ERLEADA
Open Associated Drug #1: 59676-600-12
Drug or Biological: Drug
Product Category #2: Oncology
Name Of Drug #2:: BALVERSA
Associated Drug #2: 59676-030-56
Payments Total: $11
Number of Payments:: 1
Form of Payment: In-kind items and services
Third party is a Charity:: No
Record ID:: 788902127
Being Disputed:: No
Product Related: Yes
Drug or Biological: Drug
Product Category #1: Oncology
Name of Drug #1: IMBRUVICA
Open Associated Drug #1: 57962-140-09
Drug or Biological: Drug
Product Category #2: Oncology
Name Of Drug #2:: DARZALEX
Associated Drug #2: 57894-502-05
Payments Total: $12
Number of Payments:: 1
Form of Payment: In-kind items and services
Third party is a Charity:: No
Record ID:: 788902129
Being Disputed:: No
Product Related: Yes
Drug or Biological: Drug
Product Category #1: Oncology
Name of Drug #1: ERLEADA
Open Associated Drug #1: 59676-600-12
Drug or Biological: Drug
Product Category #2: Oncology
Name Of Drug #2:: BALVERSA
Associated Drug #2: 59676-030-56
Payments Total: $14
Number of Payments:: 1
Form of Payment: In-kind items and services
Third party is a Charity:: No
Record ID:: 788902133
Being Disputed:: No
Product Related: Yes
Drug or Biological: Drug
Product Category #1: Oncology
Name of Drug #1: IMBRUVICA
Open Associated Drug #1: 57962-140-09
Drug or Biological: Drug
Product Category #2: Oncology
Name Of Drug #2:: DARZALEX
Associated Drug #2: 57894-502-05
Payments Total: $16
Number of Payments:: 1
Form of Payment: In-kind items and services
Third party is a Charity:: No
Record ID:: 788902131
Being Disputed:: No
Product Related: Yes
Drug or Biological: Drug
Product Category #1: Oncology
Name of Drug #1: IMBRUVICA
Open Associated Drug #1: 57962-140-09
Drug or Biological: Drug
Product Category #2: Oncology
Name Of Drug #2:: DARZALEX
Associated Drug #2: 57894-502-05
Payments Total: $13
Number of Payments:: 1
Form of Payment: In-kind items and services
Third party is a Charity:: No
Record ID:: 788902135
Being Disputed:: No
Product Related: Yes
Drug or Biological: Drug
Product Category #1: Oncology
Name of Drug #1: IMBRUVICA
Open Associated Drug #1: 57962-140-09
Drug or Biological: Drug
Product Category #2: Oncology
Name Of Drug #2:: DARZALEX
Associated Drug #2: 57894-502-05
1704 23rd Ave
Meridian, MS
Meridian Oncology Associates Pllc
1704 23rd Ave
Meridian Ms 39301-3103
Meridian Oncology Associates Pllc
Hematology/oncology
1704 23rd Ave
Meridian Ms 39301-3103
Meridian Oncology Associates Pllc
Hematology/oncology
1704 23rd Ave
Meridian Ms 39301-3103
Meridian Oncology Associates Pllc
Medical Oncology
1704 23rd Ave
Meridian Ms 39301-3103
Meridian Oncology Associates Pllc
Medical Oncology
View all 4 members of Meridian Oncology Associates Pllc medical group